[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-NAMS":3,"homepage-market-summary":31,"stock-stats-NAMS":174},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"NAMS","2026-10-06",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"NewAmsterdam Pharma Company N.V. Ordinary Shares","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.","100","Narrden, P7",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},22.27,23.06,23.11,21.4442,22.8,-0.53,-2.32,1264721.111894,19118,21.9738,42.205,21.02,1127366.7122711951,5.9,1421,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":155},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7818.93,44.98,0.58,true,"0.0,11.6 2.3,13.9 4.6,10.5 6.9,12.4 9.3,14.2 11.6,16.0 13.9,11.5 16.2,10.8 18.5,4.8 20.8,4.8 23.2,7.9 25.5,8.0 27.8,6.0 30.1,9.1 32.4,9.8 34.7,10.8 37.1,10.0 39.4,7.0 41.7,4.4 44.0,2.0",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",31224.47,148.03,0.48,"0.0,13.0 2.3,15.0 4.6,13.4 6.9,14.8 9.3,16.0 11.6,16.0 13.9,12.9 16.2,11.7 18.5,6.5 20.8,5.0 23.2,6.6 25.5,6.6 27.8,5.8 30.1,7.8 32.4,7.4 34.7,7.0 37.1,6.4 39.4,4.6 41.7,2.9 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51521,253,0.49,"0.0,3.6 2.3,6.3 4.6,2.0 6.9,3.3 9.3,6.0 11.6,11.3 13.9,8.7 16.2,9.5 18.5,6.4 20.8,8.0 23.2,10.9 25.5,12.3 27.8,8.2 30.1,11.2 32.4,12.3 34.7,16.0 37.1,15.8 39.4,13.7 41.7,13.0 44.0,10.8",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27599.79,122.48,0.45,"0.0,13.6 2.3,15.1 4.6,12.9 6.9,14.2 9.3,16.0 11.6,16.0 13.9,12.2 16.2,11.3 18.5,6.1 20.8,5.1 23.2,7.7 25.5,7.7 27.8,6.6 30.1,8.7 32.4,8.9 34.7,8.4 37.1,8.3 39.4,5.5 41.7,3.1 44.0,2.0",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":14,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2813.4,-20.4,-0.72,"0.0,2.0 2.3,5.2 4.6,3.9 6.9,5.8 9.3,8.0 11.6,9.4 13.9,7.7 16.2,9.2 18.5,7.6 20.8,5.8 23.2,11.6 25.5,11.9 27.8,11.5 30.1,13.7 32.4,14.8 34.7,16.0 37.1,14.8 39.4,12.0 41.7,10.0 44.0,12.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.01,-0.51,-3.29,"0.0,7.3 2.3,2.0 4.6,9.7 6.9,4.9 9.3,4.5 11.6,2.5 13.9,11.3 16.2,13.7 18.5,13.5 20.8,16.0 23.2,12.3 25.5,10.4 27.8,13.5 30.1,8.8 32.4,8.9 34.7,7.8 37.1,7.6 39.4,11.8 41.7,10.9 44.0,12.9",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",239.24,0.34,0.14,"0.0,14.1 7.3,16.0 14.7,14.6 22.0,11.8 29.3,8.2 36.7,2.4 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.63,0.74,0.22,"0.0,2.0 7.3,16.0 14.7,10.4 22.0,14.6 29.3,9.3 36.7,10.6 44.0,9.4",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",380.68,1.95,0.51,"0.0,13.7 7.3,16.0 14.7,15.0 22.0,15.4 29.3,7.1 36.7,3.0 44.0,2.0",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",0.53,202,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.24,54.01,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.17,167.09,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.2,111.75,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.9,81.77,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.47,63.75,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.87,171.58,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.46,49.73,{"name":141,"etf":142,"change":143,"price":144,"is_up":40},"Real Estate","XLRE",1.06,41.1,{"name":146,"etf":147,"change":148,"price":149,"is_up":40},"Utilities","XLU",2.98,41.16,{"name":151,"etf":152,"change":153,"price":154,"is_up":40},"Comm Services","XLC",0.04,111.65,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":40},"SPY","SPDR S&P 500 ETF",779.09,0.55,{"ticker":162,"name":163,"price":164,"change":138,"is_up":40},"QQQ","Invesco QQQ Trust",759.69,{"ticker":166,"name":167,"price":168,"change":47,"is_up":40},"DIA","SPDR Dow Jones ETF",514.56,{"ticker":170,"name":171,"price":172,"change":173,"is_up":14},"IWM","iShares Russell 2000",281.37,-0.71,{"ticker":4,"company_name":7,"current_price":16,"data_notice":175,"valuation":176,"dates":179,"share_statistics":181,"valuation_ratios":184,"enterprise_valuation":185,"financial_position":186,"financial_efficiency":188,"taxes":190,"price_statistics":191,"income_statement":198,"balance_sheet":200,"cash_flow":201,"margins":203,"dividends":204,"analyst_forecast":206,"fair_value":208,"splits":210,"fundamentals_available":14},"Dividend history, analyst price targets, ownership breakdown, short interest, stock splits, beta, WACC and Altman\u002FPiotroski scores are not available from any data source Bullzeno currently integrates, so those fields are omitted (null) rather than estimated.",{"market_cap":177,"enterprise_value":9,"summary":178},2773262320.7999997,"NAMS has a market cap of $2,773,262,320.80.",{"latest_fiscal_period_end":9,"earnings_date":9,"ex_dividend_date":9,"summary":180},"No fundamental filing dates are available for this symbol.",{"shares_outstanding":182,"owned_by_insiders":9,"owned_by_institutions":9,"summary":183},119537169,"NAMS has 119,537,169 shares outstanding.",{"pe_ratio":9,"ps_ratio":9,"pb_ratio":9,"pfcf_ratio":9,"pocf_ratio":9},{"ev_earnings":9,"ev_sales":9,"ev_ebitda":9,"ev_ebit":9,"ev_fcf":9},{"current_ratio":9,"debt_equity":9,"debt_ebitda":9,"debt_fcf":9,"summary":187},"Balance sheet data is not available for this symbol.",{"roe":9,"roa":9,"revenue_per_employee":9,"profit_per_employee":9,"employee_count":189,"asset_turnover":9},100,{"income_tax":9},{"beta_5y":9,"price_change_52w":192,"ma_50":193,"ma_200":194,"rsi_14":195,"avg_volume_20d":196,"summary":197},-31.43,25.35,31.04,58.03,1886084,"The stock price has changed by -31.43% in the last 52 weeks.",{"revenue":9,"gross_profit":9,"operating_income":9,"pretax_income":9,"net_income":9,"ebitda":9,"ebit":9,"eps":9,"summary":199},"Income statement data is not available for this symbol.",{"cash_and_equiv":9,"total_debt":9,"net_cash":9,"net_cash_per_share":9,"equity_book_value":9,"book_value_per_share":9,"working_capital":9,"summary":187},{"operating_cash_flow":9,"capital_expenditures":9,"depreciation_amortization":9,"net_borrowing":9,"free_cash_flow":9,"fcf_per_share":9,"summary":202},"Cash flow data is not available for this symbol.",{"gross_margin":9,"operating_margin":9,"pretax_margin":9,"profit_margin":9,"ebitda_margin":9,"fcf_margin":9},{"dividend_per_share":9,"dividend_yield":9,"earnings_yield":9,"fcf_yield":9,"summary":205},"NAMS has no recorded dividend payments.",{"price_target":9,"price_target_diff":9,"consensus":9,"analyst_count":9,"summary":207},"Analyst price targets and consensus ratings are not available.",{"lynch_fair_value":9,"lynch_upside":9,"graham_number":9,"graham_upside":9,"summary":209},"Graham Number and Peter Lynch Fair Value are textbook valuation formulas applied to this company's real reported EPS and book value; they are estimates, not price targets or guarantees.",{"last_split_date":9,"split_type":9,"split_ratio":9,"summary":211},"Stock split history is not available for this symbol."]